Performance of NUS Nu Skin Enterprises | -60.2% in 12m
Compare NUS with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Nu Skin Enterprises with its related Sector/Index XLP
Performance Duell NUS vs XLP
| TimeFrame | NUS | XLP |
|---|---|---|
| 1 Day | -1.52% | -0.24% |
| 1 Week | 1.04% | 1.05% |
| 1 Month | 4.92% | 5.06% |
| 3 Months | 5.27% | 6.40% |
| 6 Months | -19.9% | 14.32% |
| 12 Months | -60.2% | 6.03% |
| YTD | -32.5% | 8.16% |
| Rel. Perf. 1m | 0.32 | |
| Rel. Perf. 3m | -4.20 | |
| Rel. Perf. 6m | -3.51 | |
| Rel. Perf. 12m | -9.83 |
Is Nu Skin Enterprises a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Nu Skin Enterprises is currently (May 2024)
neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -5.19 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NUS as of May 2024 is 10.90. This means that NUS is currently overvalued and has a potential downside of -20.15% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NUS as of May 2024 is 10.90. This means that NUS is currently overvalued and has a potential downside of -20.15% (Sold with Premium).
Is NUS a buy, sell or hold?
- Strong Buy: 0
- Buy: 0
- Hold: 3
- Sell: 0
- Strong Sell: 0
Values above 0%: NUS is performing better - Values below 0%: NUS is underperforming
Compare NUS with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -0.60% | -2.01% | -37.32% | -88.49% |
| US NASDAQ 100 | QQQ | -0.92% | -4.03% | -35.99% | -95.33% |
| US Dow Jones Industrial 30 | DIA | -0.35% | -0.54% | -34.71% | -82.09% |
| German DAX 40 | DBXD | 1.28% | -0.23% | -37.09% | -74.56% |
| UK FTSE 100 | ISFU | -0.50% | -4.63% | -36.17% | -74.83% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -0.11% | 0.19% | -22.05% | -52.90% |
| Hongkong Hang Seng | HSI | -1.11% | -17.94% | -23.62% | -54.77% |
| Japan Nikkei 225 | EXX7 | -0.02% | 4.04% | -31.71% | -70.91% |
| India NIFTY 50 | INDA | -1.38% | 1.72% | -37.51% | -90.00% |
| Brasil Bovespa | EWZ | 1.13% | 1.63% | -16.17% | -72.89% |
NUS Nu Skin Enterprises vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -0.15% | 0.97% | -37.11% | -95.96% |
| Consumer Discretionary | XLY | 0.57% | -0.35% | -26.72% | -79.01% |
| Consumer Staples | XLP | -0.01% | -0.14% | -34.25% | -66.21% |
| Energy | XLE | -0.43% | 4.93% | -33.89% | -83.54% |
| Financial | XLF | -0.95% | -0.31% | -41.86% | -92.84% |
| Health Care | XLV | -0.95% | -0.38% | -34.24% | -73.43% |
| Industrial | XLI | 0.90% | 0.89% | -39.26% | -87.89% |
| Materials | XLB | 0.64% | 1.33% | -35.75% | -79.78% |
| Real Estate | XLRE | -1.20% | -3.11% | -28.73% | -71.04% |
| Technology | XLK | -1.53% | -5.10% | -34.59% | -95.78% |
| Utilities | XLU | -0.46% | -5.64% | -38.49% | -73.37% |
| Aerospace & Defense | XAR | -0.03% | -3.44% | -34.18% | -84.61% |
| Biotech | XBI | -0.41% | -5.16% | -44.02% | -67.01% |
| Homebuilder | XHB | 0.46% | -2.08% | -50.19% | -111.03% |
| Retail | XRT | 1.52% | -1.77% | -40.03% | -89.68% |
Does Nu Skin Enterprises outperform its market, is NUS a Sector Leader?
No, over the last 12 months Nu Skin Enterprises (NUS) made -60.18%, while its related Sector, the Consumer Staples Sector SPDR Fund (XLP) made 6.03%.
Over the last 3 months NUS made 5.27%, while XLP made 6.40%.
No, over the last 12 months Nu Skin Enterprises (NUS) made -60.18%, while its related Sector, the Consumer Staples Sector SPDR Fund (XLP) made 6.03%.
Over the last 3 months NUS made 5.27%, while XLP made 6.40%.
| Period | NUS | XLP | S&P 500 |
|---|---|---|---|
| 1 Month | 4.92% | 5.06% | 6.93% |
| 3 Months | 5.27% | 6.40% | 6.91% |
| 12 Months | -60.18% | 6.03% | 28.31% |